These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19430178)

  • 1. Pharmacokinetic screening strategy for discovery work-use of rodent species: lessons learnt and probing newer thoughts.
    Srinivas NR
    Drug Metab Pharmacokinet; 2009; 24(2):197-8. PubMed ID: 19430178
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New screening tools for lead compound identification.
    Sawyer TK
    Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
    [No Abstract]   [Full Text] [Related]  

  • 4. Unfinished business: target-based drug discovery.
    Brown D
    Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snapshot PK: a rapid rodent in vivo preclinical screening approach.
    Liu B; Chang J; Gordon WP; Isbell J; Zhou Y; Tuntland T
    Drug Discov Today; 2008 Apr; 13(7-8):360-7. PubMed ID: 18405850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-based virtual screening: an overview.
    Lyne PD
    Drug Discov Today; 2002 Oct; 7(20):1047-55. PubMed ID: 12546894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 21st century drug development: advances, opportunities and challenges.
    Bhogal N
    Altern Lab Anim; 2009 Sep; 37(4):335-9. PubMed ID: 19807207
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on screening-based research and some concerning trends in the literature.
    Baell JB
    Future Med Chem; 2010 Oct; 2(10):1529-46. PubMed ID: 21426147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted scoring functions for virtual screening.
    Seifert MH
    Drug Discov Today; 2009 Jun; 14(11-12):562-9. PubMed ID: 19508918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forging synergies in drug discovery.
    Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro-in vivo correlation.
    Somayaji MR; Das D; Przekwas AJ
    Drug Discov Today; 2018 Sep; 23(9):1571-1573. PubMed ID: 29428643
    [No Abstract]   [Full Text] [Related]  

  • 13. HPLC-MS/MS in drug metabolism and pharmacokinetic screening.
    Hsieh Y
    Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):93-101. PubMed ID: 18370861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From fragment to clinical candidate--a historical perspective.
    Chessari G; Woodhead AJ
    Drug Discov Today; 2009 Jul; 14(13-14):668-75. PubMed ID: 19427404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From in vivo to in vitro/in silico ADME: progress and challenges.
    Van de Waterbeemd H
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chirality in new drug development. Clinical pharmacokinetic considerations.
    Nation RL
    Clin Pharmacokinet; 1994 Oct; 27(4):249-55. PubMed ID: 7834962
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging technologies for the study of drug metabolism and pharmacokinetics.
    Hsieh Y
    Curr Drug Discov Technol; 2010 Sep; 7(3):141-2. PubMed ID: 20843297
    [No Abstract]   [Full Text] [Related]  

  • 18. Correct assessment of new compounds using in vivo screening models can reduce false positives.
    Bueters TJ; Hoogstraate J; Visser SA
    Drug Discov Today; 2009 Jan; 14(1-2):89-94. PubMed ID: 18840543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
    Roberts SA
    Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.